Imaging Genetics (IG) integrates neuroimaging and genomic data from the same individual, deepening our knowledge of the biological mechanisms behind neurodevelopmental domains and neurological disorders. Although the literature on IG has exponentially grown over the past years, the majority of studies have mainly analyzed associations between candidate brain regions and individual genetic variants. However, this strategy is not designed to deal with the complexity of neurobiological mechanisms underlying behavioral and neurodevelopmental domains. Moreover, larger sample sizes and increased multidimensionality of this type of data represents a challenge for standardizing modeling procedures in IG research. This review provides a systematic update of the methods and strategies currently used in IG studies, and serves as an analytical framework for researchers working in this field. To complement the functionalities of the Neuroconductor framework, we also describe existing R packages that implement these methodologies. In addition, we present an overview of how these methodological approaches are applied in integrating neuroimaging and genetic data.
Introduction
Information from neuroimaging is used to understand neurodevelopment, cognition and behavior at the level of the brain. The effects of complex neurological diseases and behavioral processes are likely to be reflected in the structure and/or function of the brain (Kremen and Jacobson, 2010) . In addition, some of the consistent brain responses to stimuli have a heritable basis (Bigos and Hariri, 2007; Blokland et al., 2011; Yancey et al., 2013) .
Genetics plays a pivotal role in brain structure and function, which in turn, are related to neurological diseases and behavioral processes. Brain imaging phenotypes offer an accurate measurement of biological mechanisms, all the way from gene-based pathways to neurodevelopmental domains. Moreover, it has been argued that genetic variation has a greater effect on brain imaging phenotypes than behavior. Therefore, magnetic resonance imaging (MRI)-based features can be considered as potential phenotypes (intermediate imaging markers) for a disease or neurodevelopmental domain (Gallinat et al., 2008; Gottesman and Gould, 2003) . Recent advances in neuroimaging and genetics have paved the way for further insights into neurodevelopmental domains and complex brain disorders by identifying novel imaging biomarkers and genetic risk variants. However, the combined analysis of both fields, known as Imaging Genetics (IG), provides even more potential and robustness. More specifically, by integrating neuroimaging and genomic data from the same individual, IG studies offer the opportunity to deepen our understanding of the biological mechanisms behind neurodevelopmental domains and complex brain disorders (Meyer-Lindenberg, 2012; Meyer-Lindenberg and Weinberger, 2006) . Thus, the main goal of IG consists of leveraging these interrelations to gain knowledge about neurological diseases that would otherwise have been untapped by studying neuroimaging information or genetics separately. The continual growth of both neuroimaging data and genetic information, along with the need to combine their analyses, has led to various methodological challenges (Nymberg et al., 2013) . In this respect, although the literature on IG studies has exponentially grown in recent years, a clear consensus on analytical procedures has yet to emerge.
In this review, we systematically summarize the current analytical methods used in IG studies. We provide a catalogue of methods and strategies that can serve as a reference for researchers in the field, and explain how they are implemented in R. We also discuss several examples in which these methodological approaches are applied to integrate neuroimaging and genetic data.
Methods

Literature search and selection criteria
We searched articles indexed in PubMed (National Library of Medicine) using the following terms: "Imaging Genetics", "Neuroimaging and Genetics", or "Neuroimage and Genetics" combined with "Statistical Methods", "Analytical strategies", or "Multivariate Methods". We only selected studies that met the following criteria: a) they included both genetic and neuroimaging data, b) they were written in English, and c) they were original research articles with accessible information. We excluded abstracts only, case reports, letters to the editor, and duplicated articles. Moreover, the search was limited to studies focused on the application of multivariate methods in IG, therefore other relevant clinical research or basic studies were out of the scope of the review.
Article summary and classification
A total of 367 articles were identified in PUBMED. Using these, we initially screened titles and abstracts only to identify all potentially eligible articles based on the following inclusion criteria: (a) the article must use multivariate statistical methods to analyze genetic and neuroimaging data, and (b) the article must use both, genetic and neuroimaging data in the analysis. As a result of this screening, we evaluated the full-text of 41 articles. These articles are cataloged in Table 1 , which highlights key information regarding the phenotype of interest, the neuroimaging modality, the analytical approach, and the main statistical method. All studies included in this review were performed in participants of European descent.
Results
Statistical methods and strategies in imaging genetics
IG studies typically look for three different types of genetic effects: (1) individual genetic variants that independently affect phenotypes/ imaging markers, (2) multiple genetic variants that jointly affect one phenotype/imaging marker, and (3) multiple genetic variants that jointly affect multiple phenotypes/imaging markers. Of note, neuroimaging data can be considered as either an outcome (i.e., genetic variants versus imaging markers) or an independent variable (in combination with genetic data) related to an outcome.
From a statistical point of view, data involving multiple sources can be formulated as a multi-dataset framework problem. Indeed, this is the case for IG studies, in which neuroimaging and genetic data are treated as two independent datasets. Taking this as our starting point, we defined a classification scheme for the IG studies based on the analytical strategies and statistical methods used, the dimensionality of the data, and the existence or not of a hypothesis (a hypothesis-free design (e.g., entire genome) versus a hypothesis-driven design (e.g., targeted genetic markers)) (Fig. 1) .
Data dimensionality
Analysis of individual genetic variants affecting one imaging marker
One common strategy evaluates relationships between candidate single nucleotide polymorphisms (SNPs) and brain regions of interest (ROI)/measure taken at a given voxel level related to behavioral dimensions by fitting a univariate correlation/association analysis or performing an analysis of covariance (Hoogman et al., 2014) . This type of strategy examines differences in brain structures (mean values) in relation to genotypic variation (Potkin et al., 2009; Shen et al., 2010) . However, such studies ignore the multidimensionality and complexity of data and are limited to identifying independent genetic effects Nickl-Jockschat et al., 2015) .
3.2.2. Analysis of multiple genetic variants in relation to one imaging marker 3.2.2.1. Genome-wide association analysis. More recently, genome-wide association studies (GWAS) have been used to search the entire genome for genetic polymorphisms that influence brain structure (Adams et al., 2016; Hibar et al., 2015 Hibar et al., , 2017 . GWAS has led to the discovery of associations between certain genetic variants and complex diseases, providing a better understanding of the genetic architecture of complex traits. However, GWAS is not considered to be the most feasible approach for IG as these types of studies require large samples to discover genetic effects that survive stringent multiple comparison corrections (P-values < 10 −8 ). An additional limitation is that a significant number of the SNPs reported in GWAS studies are often intergenic, and therefore create certain ambiguity when linking the causal gene to the phenotype (Visscher et al., 2017) .
3.2.2.2. Gene-set analysis. Given that complex phenotypes are likely to be influenced by numerous polymorphic genes of common pathways, gene-set analysis (GSA) has yielded important biological insights in IG (Hibar et al., 2011; Inkster et al., 2010; Vilor-Tejedor et al., 2015; Khadka et al., 2016; Lin et al., 2014a; Mattingsdal et al., 2013; Mous et al., 2015; Pérez-Palma et al., 2014) . GSA aggregates the association evidence across a set of SNPs into one combined test statistic, and then tests whether this statistic is larger than what would be expected by chance. As most reported associations with common variants have small effect sizes, combining the effect of multiple variants can improve power (over other techniques) to detect genetic risk factors for complex diseases. However, apart from being limited by the biological knowledge of the disease, the results of GSA are also are highly dependent on the definitions of the gene sets themselves and the statistical methods used. Thus, GSA is generally used as an exploratory analysis to contextualize and further explore the results obtained from GWAS (de Leeuw et al., 2015; LWang et al., 2011) .
3.2.2.3. Polygenic risk scores. Some studies calculate polygenic risk scores (PRS) to quantify the aggregate genetic influence of a trait. A PRS is the sum of all "risk" alleles weighted by their effect size as previously determined in an independent GWAS. In this way, PRSs help identify neural mechanisms that are correlated with genetic risk. This individual score, which is basically an index of genetic susceptibility for a given disorder or trait, is then checked for associations with neuroimaging phenotypes. Since a cumulative effect may be detected if enough small effects are present, testing for cumulative effects may account for the genetic heterogeneity and polygenic architecture of a disease (Mooney and Wilmot, 2015) . Moreover, PRSs may incorporate information from both GWAS hits and SNPs that are not significant at the genome-wide level. As a greater proportion of the phenotype variance is explained by PRS, they may represent an improvement over candidate gene and gene-set analyses (Dima and Breen, 2015; Wray et al., 2014) . For instance, Whalley et al. (2012) found an association between the PRS for bipolar disorder and neural activation as assessed using functional MRI (fMRI). In addition, a composite multivariate score including both genetic variants and neuroimaging features was proposed as a method to predict Alzheimer's disease (Filipovych et al., 2012) . However, a crucial aspect of polygenic risk scores approach concerns the significance threshold used as it determines the number of genetic variants examined (Dudbridge, 2013) . The fact that different criteria is used to select one or more thresholds difficult comparability across studies.
N. Vilor-Tejedor et al. Neuroscience and Biobehavioral Reviews 93 (2018) 57-70 Neuroscience and Biobehavioral Reviews 93 (2018) 57-70 3.2.2.4. Data-driven methods 3.2.2.4.1. Multidimensionality reduction methods. Data-driven methods, such as feature selection methods and multidimensionality reduction (MDRed), are another type of approach used in IG. The use of such methods is motivated by the fact that the original datasets contain a large number of genetic and neuroimaging features. Thus, MDRed strategies factorize neuroimaging and genetic data sets into a meaningful representation of reduced dimensionality (McIntosh and Mišić, 2013) . The reduction in dimensionality consists of finding the minimum number of parameters needed to account for the observed properties of the data, for the purpose of facilitating classification, visualization and comprehension of high-dimensional data (Van Der Maaten et al., 2009) .
3.2.2.4.2. Feature selection methods. Feature selection methods are used to select genetic variants that exhibit the strongest effect on the phenotype of interest. The most popular of these methods is the Least Absolute Shrinkage and Selection Operator (LASSO) multiple regression, which intrinsically performs feature selection and regularization, and shrinking coefficients of non-selected predictors towards zero (Tibshirani, 2011) . LASSO is commonly used in genetic studies (Papachristou et al., 2016; Pineda et al., 2014) , and has also been used in IG (Kohannim et al., 2012) .
In addition, some MDRed methods explore the multivariate structure of the data, and aim to select representative components. These components may reveal structures or patterns in the data that are difficult to identify a priori, and extract latent factors that represent a set of genetic variants/effects or neuroimaging-based features. To reduce the number of predictor variables and solve the multi-collinearity problem of a unique dataset, principal component analysis (PCA) is the traditional statistical method used. This multivariate method is based on maximizing the variability of the data (Ma and Dai, 2011) . Another method is independent component analysis (ICA), which can be seen as an extension of PCA when the assumptions of orthogonality and normality do not hold. ICA creates a linear representation of the data based on independent sub-components, removing correlations and higher order dependence. In addition, ICA has greater potential and provides a more useful representation than PCA, specifically in neuroimaging studies.
Another MDRed strategy is multifactorial analysis (MFA). MFA is based on a dimensionality reduction model that focuses on determining the most significant features of the analyzed data. In the context of IG, the main goal of MFA is to evaluate how much the whole set of genetic and neuroimaging intermediate phenotypes contribute to the variability of the extracted latent components, which in turn is correlated with the disease outcome. MFA is a generalization of PCA that is tailored to handle multiple tables of data. Therefore, a remarkable advantage of MFA over PCA and ICA is its ability to reduce the dimensionality of the data and simultaneously combine multiple sources of information (e.g., both genetics and neuroimaging features) into the same analysis (Abdi et al., 2013; Eslami et al., 2014) .
3.2.2.5. Epistasis. The study of SNP-SNP and/or gene-gene interactions is another strategy used to explore the effects of genetic variation on brain structure and function, and human behavior and neurodevelopment. Current methods are based on screening pair-wise interactions. For instance, Hibar et al. (2013) found a significant genegene interaction associated with temporal lobe volume. Moreover, Meda et al. (2012a) found a total of 109 significant interactions associated with right hippocampal atrophy, and 125 significant interactions associated with right entorhinal cortex atrophy. However, in addition to being difficult, the search for pairs of significant interactions also incurs high computational costs (Ehrenreich, 2017) . Moreover, while most work on epistasis focuses on pairs of interacting variants (Bloom et al., 2015) , higher-order interactions can also be present Ehrenreich, 2014, 2015) .
Analysis of multiple genetic variants in relation to multiple neuroimaging phenotypes
Currently, efforts in statistical modeling in IG studies seek to integrate multiple neuroimaging phenotypes (imaging-based features or neurodevelopmental domains) with multiple genotypes at the same time; this is in contrast to making pairwise associations or models of hierarchical structure. Unlike methods that reduce the dimensionality of genetic and/or neuroimaging datasets, joint multivariate methods simultaneously capture complex relationships between genes and brain measurements.
3.2.3.1. Massive univariate analysis. Massive univariate linear modeling (MULM) is the method of choice for modeling IG data because its results can be more easily interpreted. However, due to the high dimensionality and heterogeneity of the datasets, this strategy still produces challenges. To overcome these challenges, sparse-based statistical methods have been developed (Lin et al., 2014b) .
Sparse approaches aim to select a priori features that reduce the dimensionality of the data and facilitate interpretation of the results. We classified sparse strategies into three groups: sparse multivariate regression models (sMRM), sparse block methods (sBM), and sparse classification methods (sCM). Each of these strategies requires the modification of common methods and leads to a more accurate detection of the risk factors involved in neurodevelopmental domains.
3.2.3.2. Sparse multivariate regression. sMRM simultaneously searches multiple markers that are highly predictive of multiple imaging phenotypes. The most commonly used method is the sparse reducedrank regression (sRRR), which is an efficient way a model with a multivariate responses and multiple features . Based on LASSO, Wang et al. (2012) proposed the group-sparse multitask regression and feature-selection (G-SMuRFS) method to identify quantitative trait loci for multiple disease-relevant traits in an IG study of Alzheimer's disease. Importantly, G-SMuRFS accounts for linkage disequilibrium between SNPs. On the other hand, Wang et al. (2013) proposed a parallel version of random forest regression (PaRFR) to optimize computational cost. PaRFR ranks SNPs associated with the phenotype, and produces pair-wise measures of genetic proximity that can be directly compared to pair-wise measures of phenotypic proximity. Compared to other sparse methods, these methods have the advantage of being able to simultaneously perform dimension reduction and coefficient estimation, thereby improving predictive performance in the analysis (Kharratzadeh and Coates, 2016) .
3.2.3.3. Sparse block methods. sBM are used to account for pleiotropic effects (i.e., when one genotype influences two or more seemingly unrelated brain structures or neurodevelopmental domains). In sBM, data are not differentiated in terms of regressors and responses, but rather each column of the data matrix is considered as an independent variable. The most commonly used methods are sparse Partial Least Squares (PLS; Wold et al., 1983; Krishnan et al., 2011) , sparse Canonical Correlation Analysis (CCA; Correa et al., 2008; Sui et al., 2010) , and parallel ICA (Meda et al., 2010; Pearlson et al., 2015) . PLS regression is used to model associations between two blocks of variables in which latent variables are searched such that their covariance is maximal. The CCA method, which maximizes the correlation between latent variables, is quite similar. Both methods are closely related and are often used in IG studies (Grellmann et al., 2015; Le Floch et al., 2012) . Furthermore, some methodological extensions have been implemented, including incorporating correlation and group-like structure into the model , and introducing group constraints in which the fMRI voxels are grouped by ROIs and the SNPs by genes (Lin, Calhoun, et al., 2014a) . Moreover, to solve the timeconsuming problems associated with high-volume datasets in real applications, pICA was proposed as an optimized extension of ICA. This optimized method uses multiple processors in parallel and is based Neuroscience and Biobehavioral Reviews 93 (2018) The main advantage of these methods is the possibility to fully integrate multiple sources of datasets, and include a preliminary step of dimensionality reduction.
3.2.3.4. Sparse classification methods. sCMs have also been applied in IG to achieve better discrimination of disease status based on multiple imaging and multiple genetic features. These methods include machine learning techniques, which can be also used to define gene-sets or pathways that best predict the imaging phenotype (Cao et al., 2013) , Kernel machine-based methods (Ge et al., 2015 (Ge et al., , 2012 Zhang et al., 2014) and Bayesian methods (Batmanghelich et al., 2013; Stingo et al., 2013; Zhe et al., 2014) . In general, sCMs apply a sparse representation coefficient during classification, which contains very important discriminating information. Therefore, sCM have more power to discriminate than other previously described methods (Li and Ngom, 2013; Wen et al., 2016) .
Statistical methods used in analyzing different data modalities
Extensions to multivariate methodologies increase the analytical possibilities for IG studies. However, we showed that most (62.5%) studies that combine genetic and imaging data are based on sBM methods, data-driven analyses and sMRM. In terms of sBM, the most widely used methods are sCCA (20%) and pICA (15%). Among the datadriven methods, the most frequently used are LASSO (7.5%) and PCA (6%) [Fig. 2] .
Statistical methods by neuroimaging technique
Most IG studies discussed in this review imaged the brain using either structural MRI (sMRI) or fMRI, while a few studies were also based on diffusion tensor imaging (DTI) or other methods [ Fig. 3a] . Stratifying the statistical methods according to neuroimaging technique (sMRI or fRMI), we found that sBS methods are still the most widely used method for analyzing both sMRI (55.6%) and fMRI (30.8%) data. While both neuroimaging methods techniques coincide in a nearly similar use of sCM, data-driven, and GSA, they differ with respect to the use of sMRM, which seems to be specific for analyzing fMRI data [ Fig. 3b ].
Statistical methods by imaging marker/disease
Regarding outcomes, IG studies can be divided into two types: studies that have (1) disease or functional capacity outcomes (30.6%), where neuroimaging data is used in combination with genetic data to predict the disease; and (2) neuroimaging feature outcomes (i.e., imagebased features) such as, diffusivity values and/or fractional anisotropy (48.9%) [ Fig. 4a ]. Stratifying the classification of statistical methods by taking into account neuroimaging intermediate phenotypes as principal phenotypes of the study, we observed that sBM (42.2%) and sMRM (21.1%) are still the most popular methods. The most commonly analyzed diseases were Alzheimer´s disease (16.3%) and Schizophrenia (8.2%). While for Schizophrenia, sBM (66.7%) and sCM (33.3%) were the most popular methods, Alzheimer´s disease studies displayed much more heterogeneity in terms of the specific methodology used [ Fig. 4b ].
Multiple comparison correction strategies
The dimensionality of the data in IG studies is the principal handicap in acquiring analytical perspectives, exacerbating existing issues regarding the reliability and interpretability of the results. Moreover, independently testing millions of SNPs (population-wide) for associations on the one hand, and millions of neuroimaging-based measures on the other, reduces statistical power due to multiple testing correction. Thus, large-scale analysis of genetic versus brain data requires new 
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strategies for controlling Type-I error (incorrect rejection of a true null hypothesis, also known as a false positive). While most types of research accept a confidence rate of 95%, the hundreds of thousands of statistical tests composing an IG analysis increases the likelihood of a Type-I error. Hence, a confidence rate of 95% seems insufficient to properly account for multiple testing in IG studies. The most widely known and used method designed to counteract this problem, especially in genetics, is the Bonferroni correction, which defines a new confidence level by taking into account the number of tests performed in the analysis. However, this method has also received criticism for being very conservative (Perneger, 1998) , particularly in situations where there are a large number of tests and/or the test statistics are correlated (e.g., in linkage disequilibrium (LD) in the genetics context). In such a situation, Bonferroni correction comes at the cost of increasing the likelihood of producing false negatives, and in turn, decreases the power of the test (i.e., the probability of correctly rejecting a false null hypothesis). For this reason, significance thresholds have been established in the genetics context using simulation studies that account for LD between SNPs. In this case, genome-wide significance was set to α = 5 × 10 −8 and suggestive evidence of association was set to α = 10 -5 (Duggal et al., 2008; Pe'er et al., 2008) . The challenge of choosing an appropriate threshold becomes even more difficult in the neuroimaging context. In genetics, the Bonferroni correction is an extended option available for correcting for multiple testing. However, because of the significant spatial correlation of neuroimaging data, such as in the simultaneous study of grey matter volume and subcortical structures, or cortical thickness and cortical surface areas, this method is not optimal in this context either. Alternatives include the use of Gaussian random field theory (Brett et al., 2003) , and/or non-parametric permutation correction techniques (Nichols and Holmes, 2002) .
Other methods such as the false discovery rate (FDR), which controls the proportion of false positives among all rejected tests (Benjamini and Hochberg, 1995) are often used in the neuroimaging context. FDR can be less stringent and lead to a gain in power. In addition, since FDR work only on the p-value, it can be applied to any valid statistical test. However, FDR cannot be applied in the genomic context because it assumes that many features do not follow the null hypothesis, and this is not the case for genetic data where only a few SNPs are expected to be significantly associated with the outcome of interest (Dudbridge et al., 2006) . FDR methods together with the use of arbitrary uncorrected thresholds (e.g., p < 0.001) are an extended and generalized practice to correct multiple comparisons problem in the neuroimaging field. The main disadvantage is that null findings are hard to disseminate, hence it is difficult to refute false positives established in the literature (Christley, 2010; Forstmeier et al., 2017) . Table 2 shows R and Bioconductor packages designed to perform multivariate analyses of one, two, or more datasets. This information is not exhaustive, but aims to provide a list of packages that can be used to perform the data analyses described in this review.
R packages
We are aware that some IG researchers analyze their data using Matlab software. However, we prefer to provide a list of R packages due to the following advantages: (1) the functions and packages are freely available through an open source project such as R and Bioconductor; (2) R not only contains functions and packages that deal with the integrative analyses described here, but also includes a lot of other packages capable of performing different types of neuroimaging data analyses (R CRAN Task; https://cran.r-project.org/web/views/ MedicalImaging.html); (3) R functions can be combined with Bioconductor packages that are designed to deal with genomic data; and (4) there is a big initiative called Neuroconductor (https:// neuroconductor.org/) that is implementing methods and tools to analyze imaging data. Neuroconductor started with 58 inter-operable packages that cover multiple areas of imaging including visualization, data processing and storage, and statistical inference. It enables the IG community to submit new packages addressing novel issues and methods. Finally, another advantage of working under the R environment is that current techniques are continuously evolving and most of the R packages that deal with new data problems are available at GitHub repositories where developmental version can be easily installed into R. Percentage of studies using fMRI classified by analytical approach. Legend: sMRI: structural magnetic resonance imaging; fMRI: functional magnetic resonance imaging; DTI: diffusion tensor imaging.
N. Vilor-Tejedor et al. Neuroscience and Biobehavioral Reviews 93 (2018) Neuroscience and Biobehavioral Reviews 93 (2018) 57-70 combinations of the original variables, and that the PCs are independent (e.g., orthogonal). All of these assumptions can be relaxed by using other approaches. For instance, non-linear PCA (the homals function in the homals package; Leeuw and Mair, 2009) can be used when the assumption of linearity does not hold. Additionally, this package can also deal with data that is composed of different types of variables (categorical and numerical). The normality assumption, on the other hand, can be overcome by using independent component analysis (ICA) implemented in the fastICA package (Hyvärinen, 2013) . All of these methods can be used to visualize variables and samples in two or three dimensions (i.e., PCs). While these methods can be used in a preliminary data analysis to discover patterns and possible associations, they are by no means a formal statistical test to decide which set of variables is relevant.
3.5.1.2. Variable selection methods. The problem of variable selection can be addressed by using LASSO or elastic net methods, implemented in the glmnet package for example (Friedman et al., 2010; Simon et al., 2011; Tibshirani et al., 2018) . Furthermore, a newer version of this technique capable of dealing with large datasets is implemented in the biglasso package (Zeng and Breheny, 2017) .
Analysis of multiple tables
There is also a wide variety of packages that can perform multivariate data analysis by integrating two or more tables. CCA is the counterpart of PCA when analyzing two tables (cc function of the cca package; Legendre et al., 2012) . The assumptions made when using this methodology are basically the same as those of PCA. However, in CCA the PCs also maximize the correlation between the two tables since it assumes normality. This assumption can be overcome by using coinertia analysis (cia function of the made4 package; Culhane et al., 2005) . CIA can be seen as the non-parametric version of CCA, and estimates PCs by maximizing the covariance between tables. It is robust against outliers and can address the ≪ n p ( ) problem without any extra task. In contrast, IG studies using CCA to analyze a large amount of SNP data require sparse or penalized versions of CCA. This problem is very well addressed in the CCA function of the PMA package (Witten et al., 2009 ). This package also contains the multiCCA function, which can analyze more than two tables using a canonical correlation approach. Based on our experience, we highly recommend its use because it is quite fast even when analyzing thousands of features. The only limitation of this package is visualization. Nonetheless, we have developed some functions that create appropriate plots to help interpret multiCCA results. These functions are available on request.
CCA and CIA assume that both tables are interchangeable. That is, we are interested in the correlation between tables, or how they are associated. In some data analyses, one of the tables can be considered as the outcome. For instance, in IG one may argue that SNPs can explain observed differences in volumes. In this case, the relationship between the two tables cannot be considered symmetrical. This problem can be addressed by using redundancy analysis (RDA). RDA considers one of the tables as dependent (volumes) and the other one as independent (SNPs). The analysis of multiple tables using the ICA approach is implemented in the pICA function from the PGICA package (Eloyan et al., 2013) .
3.5.2.1. Regularized methods. In some IG studies, it can be interesting to analyze the complete genome or a large number of features. In such a situation, multivariate methods must be extended to account for having more variables (p) than individuals (n) ≪ n p ( ). To this end, several R packages implement a regularized or sparse version of standard multivariate methods. These methods require the estimation of a penalized parameter that is normally estimated using a crossvalidation procedure. Sometimes, this can be very demanding in terms of computational time. However, these processes can be sped up by using parallel implementations of these algorithms.
We would like to highlight that the regularized generalized canonical correlation (RGCCA) method is a generalization of almost all of the multivariate methods described here (M. Tenenhaus et al., 2017) . The rgcca package illustrates how to perform, among others, PCA, CCA, RDA, GCCA and MCIA. Moreover, the sgcca function within this package makes it possible to combine these methods using a variable selection procedure (A. Tenenhaus et al., 2014) .
Discussion
In this review, we summarize the current literature on statistical methods for Imaging Genetics. These studies demonstrate that the use of accurate statistical models for the joint analysis of imaging and genetics date facilitates our understanding of complex neurodevelopmental domains.
In contrast to single association analyses, where the p-values for association and effect size are computed for each variant independently, multivariate techniques aim to decompose the data into its most important sources of variation. Dimensionality reduction techniques make it possible to determine the degree to which the whole set of genetic and/or neuroimaging markers contributes to the variability of the symptomatology in a joint, rather than individual manner. Multivariate data reduction techniques select the best combinations of variables, offering a new reference basis for observing the dataset. IG components can therefore be associated with biological mechanisms (e.g., the identification of new target genes. Then, on one hand, by obtaining a set of components, is it possible to rank the importance of the original variables. This can be done by taking into account, for instance, their correlation/association with the obtained components. On the other hand, after select significant results, then univariate models can be made to quantify the effect and / or to validate it in other data sets. This procedure allows to perform a discovery step without relying on a univariate approach, and in turn, obtain a meaningfully way to quantify the effect size.
The vast majority of the IG studies reviewed here used sparse representation methods. Sparse models overcome the difficulty of modeling IG data, which is usually characterized by a smaller sample size than the number of features by reducing the dimensionality of the data for easier interpretation of the results. Sparse models also provide a powerful approach for considering correlation structure, something which is absent in many other strategies. In addition, sparse models provide a flexible way to incorporate a priori biological knowledge into the model, and also facilitate the discovery complex relationships between imaging and genetic features (Lin et al., 2014) .
There is no doubt that multivariate methods are highly suited for providing insight into the links between genes and neurodevelopmental domains via intermediate imaging markers . However, even though there is a clear need to implement multivariate methods in IG studies, these novel techniques have had limited impact in terms of real scientific discoveries. This could be because (1) traditional methods that perform well for moderate sample sizes do not scale up well to massive data, and (2) statistical methods that perform well for low-dimensional data face significant challenges in analyzing highdimensional data. Multivariate association analysis methods are not easily applied, and despite the efforts thus far, novel methods still need to be developed and standardized to deal with the superdimensionality and interpretability of the data. To limit the analytical burden on human and computational resources, this would ideally make use of already available results from collaborative efforts.
On the other hand, brain imaging is increasingly recognized as providing intermediate phenotypes to understand the complex pathway between genetics and behavioral or clinical phenotypes (Lenzenweger, 2013; Meyer-Lindenberg and Weinberger, 2006 Neuroscience and Biobehavioral Reviews 93 (2018) 57-70 neurodevelopmental domains. For instance, the association between a particular behavioral feature and thickness in a specific cortical area may be a clue that the mechanisms involved in the development of that cortical region are also relevant to that behavior (Meyer-Lindenberg and Weinberger, 2006) . Moreover, intermediate phenotypes are thought to be "simpler" at a genetic level. Genetic effects on these measures would be stronger and independent of clinical status, thereby making their detection possible within samples of the general population. From this, genetic associations could be captured more objectively and accurately (Braff and Tamminga, 2017; Geschwind and Flint, 2015; Gottesman and Gould, 2003; Iacono et al., 2014; Meyer-Lindenberg and Weinberger, 2006; Munafò and Flint, 2014 (Bookheimer et al., 2000) , brain structure (Winkler et al., 2010) , functional connectivity (Dennis and Thompson, 2014) . Specifically, in our review we found that more than half of the studies take advantage of intermediate imaging markers to elucidate relationships between genetic variants and neurodevelopmental outcomes. Despite this fact, there are still many challenges to overcome in modeling IG data (Bigos and Weinberger, 2010; Bogdan et al., 2017) . For instance, while intermediate imaging markers have greater power to detect associations between genetic markers and neurodevelopmental and behavioral outcomes, larger datasets are needed to obtain sufficient power to detect genome-wide associations, and to determine how much of the phenotypic variance can be accounted for by those genetic factors. Moreover, the availability of multiscale and multimodal IG data creates computational challenges for developing powerful, efficient and biologically interpretable methods. Together with the low effect sizes of individual genetic variants and the heterogeneity of most neurodevelopmental domains, this challenges the discovery of significant effects (Franke et al., 2016; Murphy et al., 2013) .
Importantly, as the associations described in this review are focused on European populations (as this was what we found in the literature), interpretation of the results cannot be universally applied to populations of different genetic backgrounds (Popejoy and Fullerton, 2016) . In addition, replication of IG results is confronted with distinct replicability issues to those of genetic and neuroimaging studies, as well as those of complex analysis strategies. While replication in independent genetic studies is often required to validate a finding (Ioannidis et al., 2014; Schnack and Kahn, 2016) , neuroimaging results are challenged by the lack of power for a reliable finding (Nord et al., 2017; Poldrack et al., 2017) . In addition, complex analyses should be tested for robustness and reproducibility (Peng, 2011) . A challenging question is then posed: How and to what extent should an IG finding be considered valid? While fully replicating an experiment, or performing a power analysis on exploratory studies may not be an option, general guidelines for exploratory analyses can be followed. Analytical flexibility can be met with an internal replication or robustness assessment using leaveone-out validation methods (Fletcher and Grafton, 2013) . Reproducibility can be assessed by applying the same methods to a random subsample in which the exploratory analysis was not conducted (Picciotto, 2018) . In addition, different methods and analytical strategies should be compared within studies. Given that IG is a young field, standards for sound research will begin to emerge as more studies are conducted.
Even with the disadvantages and problems that can be produced in statistical inference and interpretation, we highlight that recent advances in multivariate analysis, large data set analysis, and big data science have great potential to achieve new analytical perspectives. This will ultimately advance our understanding of the underlying biology of many neurodevelopmental domains. In this sense, collaborative efforts between many studies increases the statistical power needed to find and replicate those genetic variants related to changes in brain structure and function. Working with large datasets also has an impact on the tools used in the data analyses. This issue has been considered in the R framework by creating specific infrastructures to deal with big data problems. As an example, the bigmemory package is designed to manage large matrices with shared memory and memorymapped files. Some packages implement multivariate methods using the big matrices base of the bigmemory infrastructure (Kane, 2015) . For instance, the bigpca package is designed to perform PCA on very large tables, and uses objects of class big.matrix as input (Cooper, 2015) . These methods not only dramatically reduce the computational time required to analyze complete GWAS data, but also allow the user to properly manage such amounts of information in R. As a result, one may use the prcomp or princomp functions of the stats package to compute a PCA with a small to moderate number of features and samples. However, performing PCA with thousands of variants in a large number of individuals with these same functions is not recommended. Instead, the big.PCA function implemented in the bigpca package can be used to solve memory and computing issues. Hence, the reinforcement and development of new, specific statistical methods and computational procedures will become crucial as more applications for IG arise in the future.
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